| 000 | 01380 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250512114317.0 | ||
| 264 | 0 | _c19731115 | |
| 008 | 197311s 0 0 fre d | ||
| 022 | _a0079-6344 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTriau, R | |
| 245 | 0 | 0 |
_a[Cerebrospinal meningitis and anti-meningococcal vaccination]. _h[electronic resource] |
| 260 |
_bProgress in immunobiological standardization _c1971 |
||
| 300 |
_a454-71 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Review | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAfrica |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAnti-Bacterial Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aBacterial Vaccines _xadministration & dosage |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aChild, Preschool |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 | _aDisease Outbreaks |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfant |
| 650 | 0 | 4 | _aInfant, Newborn |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMeningitis _xetiology |
| 650 | 0 | 4 |
_aMeningitis, Meningococcal _xdrug therapy |
| 650 | 0 | 4 |
_aMeningococcal Infections _xepidemiology |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aMilitary Medicine |
| 650 | 0 | 4 | _aMorocco |
| 650 | 0 | 4 |
_aSulfonamides _xtherapeutic use |
| 650 | 0 | 4 | _aUnited States |
| 650 | 0 | 4 | _aVaccination |
| 773 | 0 |
_tProgress in immunobiological standardization _gvol. 5 _gp. 454-71 |
|
| 999 |
_c4585728 _d4585728 |
||